Trials / Completed
CompletedNCT01913548
Multi-Center Study of Iron Overload: Survey Study (MCSIO)
Modulation of Iron Deposition in Sickle Cell Disease and Other Hemoglobinopathies SURVEY STUDY
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 423 (actual)
- Sponsor
- UCSF Benioff Children's Hospital Oakland · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate that a sufficient number of iron-overloaded thalassemia (THAL), Sickle Cell Disease (SCD)and Diamond Blackfan Anemia (DBA) populations with similar duration of chronic transfusion, and age at start of transfusions would be available for a confirmatory study. The study will examine the hypothesis that a chronic inflammatory state in SCD leads to hepcidin- and cytokine-mediated iron withholding within the RES (reticuloendothelial system), lower plasma NTBI (non-transferrin bound iron) levels, less distribution of iron to the heart in SCD.
Detailed description
A detailed iron burden, transfusion and chelation history will be obtained from chart review or from participant recall. Iron burden data will include: 1) documentation of liver iron, and 2) average annual ferritin values. Transfusion data will include: (1) age at onset of regular transfusions, (2) years of chronic transfusion therapy, and (3) pre-transfusion Hb calculated as average of all assessments for each year.
Conditions
Timeline
- Start date
- 2010-03-31
- Primary completion
- 2013-08-31
- Completion
- 2013-10-31
- First posted
- 2013-08-01
- Last updated
- 2020-09-23
Locations
8 sites across 3 countries: United States, Germany, United Kingdom
Source: ClinicalTrials.gov record NCT01913548. Inclusion in this directory is not an endorsement.